Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Endocrinology/Metabolics

1594

Endocrinology is the branch of medicine dealing with endocrine and metabolic disorders. The endocrine system is made of hormone producing glands, such as the thyroid, parathyroid, pancreas, ovaries, testes, adrenals, pituitary, and hypothalamus. These hormones control reproduction, metabolism, and growth and development.

Endocrinologists are specially trained doctors in treating hormone imbalances and problems.

Most endocrine disorders are chronic and need continuous treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid and hyperparathyroid disorders, and osteoporosis. Some less common but serious endocrine disorders include, but are not limited to: Addison’s disease, Cushing’s syndrome, pheochromocytoma, and disorders of sexual development.

In the United States, the most common endocrine disease is diabetes mellitus. Diabetes mellitus is a group of diseases categorized by a deficiency in insulin production or the ability of the body to use it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes has made endocrinology/metabolics one of the most in-demand and important medical sects.

RSS Feeds

All reports in Endocrinology/Metabolics

< prev 1  2  3  4  next >
2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies
4/18/2012 | published by: Venture Planning Group
... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ...  |  more...
$7,500.00
The 2012 Endocrine Function Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment
3/28/2012 | published by: Venture Planning Group
... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ...  |  more...
$7,500.00
Growth Hormone Deficiency – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency. 'Growth Hormone ...  |  more...
$500.00
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
3/1/2012 | published by: GBI Research
... to 2018-Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients”, which provides insights into the endocrine disease therapeutics market until 2018. The report is built using data and information ...  |  more...
$3,500.00
Testosterone Replacement Therapy (TRT)
3/1/2012 | published by: Global Industry Analysts
... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ...  |  more...
$4,600.00
Growth Disorders – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Disorders. 'Growth Disorders - Pipeline Review, H1 2012' ...  |  more...
$500.00
Growth Hormone Deficiency Global Clinical Trials Review, H2 2011
10/11/2011 | published by: GlobalData
... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ...  |  more...
$1,000.00
Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
10/3/2011 | published by: GBI Research
... Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value”, which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced ...  |  more...
$3,500.00
Hormone Replacement Therapy (HRT)
9/1/2011 | published by: Global Industry Analysts
... provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 42 companies including many key and niche players such as Bayer HealthCare Pharmaceuticals, Inc., Besins ...  |  more...
$4,200.00
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health
5/25/2011 | published by: Spectra Intelligence
... Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to an analysis of current product markets, research and development themes, and company activities ...  |  more...
$2,815.00
Testosterone Replacement Therapy (TRT)
4/1/2011 | published by: Global Industry Analysts
... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ...  |  more...
$4,600.00
Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... Hormone Disorders) therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly And Gigantism (Growth Hormone Disorders), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...  |  more...
$500.00
Female Sexual Dysfunction - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Sexual Dysfunction. 'Female Sexual ...  |  more...
$500.00
Hypercalcemia Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and ...  |  more...
$1,495.00
Hypocalcemia Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and ...  |  more...
$1,495.00
Hypogonadism Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and ...  |  more...
$1,495.00
Growth Hormone Deficiency Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail ...  |  more...
$1,495.00
The Pricing and Reimbursement Environment for Metabolic Disease Therapies
3/1/2011 | published by: Decision Resources
... metabolic disorders a priority and generally offer generous coverage of drugs for these diseases. Spending in this therapeutic area is growing rapidly, prompting payers to review their cost-containment strategies. Drug manufacturers need to be aware ...  |  more...
$4,600.00
Competitor Analysis: Human Growth Hormone (hGH)
1/1/2011 | published by: La Merie Publishing
... growth hormone deficiency (GHD) in childrens and adults and related diseases. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. ...  |  more...
$454.00
Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q4 2010
12/27/2010 | published by: Global Markets Direct
... report provides information on the therapeutic development for Acromegaly and Gigantism   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...  |  more...
$500.00
Cachexia - Pipeline Review, Q4 2010
12/8/2010 | published by: Global Markets Direct
... latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cachexia. “Cachexia-Pipeline Review 2010, Q4 2010” is built using data and information sourced from ...  |  more...
$500.00
Growth Disorders - Pipeline Review, Q4 2010
12/8/2010 | published by: Global Markets Direct
... Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Disorders. “Growth Disorders-Pipeline Review 2010, Q4 2010” is built ...  |  more...
$500.00
Hormone Replacement Therapy - Pipeline Review, Q4 2010
12/8/2010 | published by: Global Markets Direct
... therapeutic development for Hormone Replacement Therapy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hormone Replacement Therapy. “Hormone Replacement Therapy-Pipeline ...  |  more...
$500.00
The World Market for Diabetes Treatments
10/1/2010 | published by: Kalorama Information
... pharmaceutical sector, and is one of the few pharmaceutical sectors that are likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an ...  |  more...
$995.00
Pipeline and Commercial Insight: Hormonal Replacement Therapy for Menopausal Symptoms - Safety fears continue to haunt the market
9/27/2010 | published by: Datamonitor
... this with Pfizer's acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain. Scope Patient potential analysis across the seven major markets Review of the key needs supported by key ...  |  more...
$15,200.00
< prev 1  2  3  4  next >